Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

11.54
Delayed Data
As of Jun 23
 +0.52 / +4.72%
Today’s Change
4.88
Today|||52-Week Range
11.61
+66.28%
Year-to-Date

Today’s Trading

Previous close11.02
Today’s open11.01
Day’s range10.85 - 11.61
Volume760,862
Average volume (3 months)254,258
Market cap$534.2M
Dividend yield--
Data as of 4:05pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+65.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+5.30%
P/E ratio16.3
Price/Sales3.16
Price/Book5.96

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.11+1.02%
NVTAInvitae Corp-0.04-0.42%
NEONeogenomics Inc+0.17+1.95%
RDNTRadNet Inc+0.20+2.67%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateOctober 13, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$102.8M
Annual profit (last year)$45.3M
Net profit margin44.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts